CONMED Corporation
CNMD
$54.73
$0.450.83%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.54% | -69.37% | 2.07% | 209.29% | 118.29% |
| Total Depreciation and Amortization | 4.10% | 1.19% | 1.86% | 0.57% | -1.25% |
| Total Amortization of Deferred Charges | -1.28% | 2.56% | -11.13% | -6.66% | -6.64% |
| Total Other Non-Cash Items | 1,222.22% | 872.18% | 855.23% | -303.34% | -107.26% |
| Change in Net Operating Assets | -218.86% | 105.49% | -520.64% | -33.53% | 57.86% |
| Cash from Operations | -32.73% | 42.63% | -23.15% | 11.00% | 62.36% |
| Capital Expenditure | -59.58% | -85.70% | 16.79% | 36.61% | 20.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -59.58% | -43.93% | 16.79% | 36.61% | 35.07% |
| Total Debt Issued | -1.63% | -34.65% | -16.67% | -20.99% | 29.11% |
| Total Debt Repaid | 7.97% | 24.12% | 15.45% | 20.66% | -25.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.45% | -0.44% | -0.46% | -0.29% | -0.79% |
| Other Financing Activities | 21.67% | 71.59% | 29.52% | -827.95% | -205.33% |
| Cash from Financing | 39.83% | -66.91% | 13.10% | -4.30% | -122.80% |
| Foreign Exchange rate Adjustments | 354.78% | 259.65% | -319.22% | 175.88% | -20,466.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.91% | 15.35% | -125.72% | 261.64% | -468.24% |